Esperion Therapeutics

Esperion Therapeutics is a biopharmaceutical company that develops innovative medicines to help lower high cholesterol levels, especially in patients who are at risk of heart disease. Their main focus is on creating oral medications that can reduce LDL cholesterol, often called "bad" cholesterol, when other treatments are not enough. By offering more effective and easier-to-take options, Esperion aims to improve cardiovascular health and reduce the risk of heart attacks and strokes. They work closely with healthcare providers to bring new therapies to patients who need them most.